ALA 4.62% 15.5¢ arovella therapeutics limited

Ann: AGM Presentation, page-6

  1. 111 Posts.
    lightbulb Created with Sketch. 62
    Pathetic. No Revenue projections. No timeline on royalties from existing deals. Disgraceful American expenditure. Confirmation of Cap raise after consolidation with therefore further dilution. Why would anyone invest more capital if its guaranteed to be diluted?
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.